Back to Search Start Over

Heart valve disease gender difference in the era of transcatheter treatment

Authors :
Aurigemma, Cristina
Burzotta, Francesco
Trani, Carlo
Aurigemma C.
Burzotta F. (ORCID:0000-0002-6569-9401)
Trani C. (ORCID:0000-0001-9777-013X)
Aurigemma, Cristina
Burzotta, Francesco
Trani, Carlo
Aurigemma C.
Burzotta F. (ORCID:0000-0002-6569-9401)
Trani C. (ORCID:0000-0001-9777-013X)
Publication Year :
2023

Abstract

Available data have demonstrated important sex-related differences in patients with valvular heart disease, regarding clinical presentation, treatment, and outcomes. Although the calcific aortic stenosis (AS) is more frequent in men compared to women, the majority of AS patients over 80 years old are women, in whom fibrotic remodeling of aortic valve is typically found. Mitral valve disease is more common in women. However females are under-referred or delayed referrals to treatment, probably due to the absence of sex-based LV dimension values guiding surgical timing. The development of transcatheter devices have revolutionized the treatment of valvular heart disease and increased the interest in this topic. In this context, the consideration of gender differences in presentation, diagnosis, treatment success, and prognosis is of great importance. Copyright ©2023 Heart, Vessels and Transplantation.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1439664066
Document Type :
Electronic Resource